Good Health Can’t Wait.

Good Health Can’t Wait.
Dr. Reddy’s Laboratories Limited
Five Years
at a Glance
(` MILLION)
YEAR ENDING MARCH 31 2015 2014 2013 2012 2011
INCOME STATEMENT DATA
Revenues 148,189 132,170 116,266 96,737 74,693
Cost of revenues 62,786 56,369 55,687 43,432 34,430
Gross profit 85,403 75,801 60,579 53,305 40,263
as a % of revenues 57.6 57.4 52.1 55.1 53.9
OPERATING EXPENSES
Selling, general and administrative expenses* 42,585 38,783 34,272 29,907 23,689
Research and development expenses 17,449 12,402 7,674 5,911 5,060
Other Operating (income)/expenses, net (917) (1,416) (2,479) (765) (1,115)
Total operating expenses 59,117 49,769 39,467 35,053 27,634
Operating income 26,286 26,032 21,112 18,252 12,629
as a % of revenues 18 20 18 19 17
FINANCE COSTS, NET
Finance income 2,774 1,674 1,478 1,227 173
Finance expenses (1,092) (1,274) (1,018) (1,067) (362)
Finance (expense)/income, net 1,682 400 460 160 (189)
Share of profit of equity accounted investees, net of income
195 174 104 54 3
tax
Profit before income tax 28,163 26,606 21,676 18,466 12,443
Income tax benefit/(expense) (5,984) (5,094) (4,900) (4,204) (1,403)
Profit for the year 22,179 21,512 16,776 14,262 11,040
as a % of revenues 15 16 14 15 15
EARNINGS PER SHARE (`)
– Basic 130.2 126.5 98.8 84.2 65.3
– Diluted 129.7 126.0 98.4 83.8 65.0
Dividend declared per share (`) 20.0 18.0 15.0 13.8 11.3
BALANCE SHEET DATA
Cash and cash equivalents, net of bank overdraft 5,394 8,451 5,054 7,379 5,660
Operating working capital** 55,624 46,526 41,710 35,189 25,194
Total assets 194,762 170,223 142,369 119,477 95,005
Total long-term debt, excluding current portion 14,307 20,740 12,625 16,335 5,271
Total stockholders' equity 111,302 90,801 72,805 57,287 45,803
ADDITIONAL DATA
NET CASH PROVIDED BY/(USED IN)
Operating activities 25,033 19,463 13,317 16,150 8,009
Investing activities (22,904) (16,620) (13,944) (18,665) (8,658)
Financing activities (4,118) (217) (1,792) 3,735 (377)
Effect of exchange rate changes on cash (1,068) 771 94 499 141
Expenditure on property, plant and equipment & Intangibles (15,327) (10,627) (7,336) (8,585) (11,606)
Notes:
Includes impairment of goodwill and other intangibles and reversal of impairment. Figures are regrouped for previous years
** Operating working capital = Trade receivables + Inventories - Trade payables
All figures are based on IFRS consolidated financial statements
82